MY167777A - A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site - Google Patents

A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site

Info

Publication number
MY167777A
MY167777A MYPI2018700176A MYPI2018700176A MY167777A MY 167777 A MY167777 A MY 167777A MY PI2018700176 A MYPI2018700176 A MY PI2018700176A MY PI2018700176 A MYPI2018700176 A MY PI2018700176A MY 167777 A MY167777 A MY 167777A
Authority
MY
Malaysia
Prior art keywords
composition
residence time
application site
pharmaceutical composition
hydrophilic
Prior art date
Application number
MYPI2018700176A
Other languages
English (en)
Inventor
Jens Hansen
Martin Eduardo Santocildes Romero
Original Assignee
Dermtreat Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtreat Aps filed Critical Dermtreat Aps
Publication of MY167777A publication Critical patent/MY167777A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Nonwoven Fabrics (AREA)
MYPI2018700176A 2015-11-19 2016-11-18 A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site MY167777A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201570745 2015-11-19

Publications (1)

Publication Number Publication Date
MY167777A true MY167777A (en) 2018-09-25

Family

ID=58718438

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018700176A MY167777A (en) 2015-11-19 2016-11-18 A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site

Country Status (17)

Country Link
US (4) US20180221295A1 (enExample)
EP (1) EP3334412B1 (enExample)
JP (2) JP6606279B2 (enExample)
KR (3) KR20190067280A (enExample)
CN (1) CN108135833B (enExample)
AU (2) AU2016358266B2 (enExample)
BR (1) BR112018001978A2 (enExample)
CA (1) CA2993377C (enExample)
DK (1) DK3334412T3 (enExample)
ES (1) ES2900741T3 (enExample)
IL (1) IL258093B (enExample)
MX (1) MX391778B (enExample)
MY (1) MY167777A (enExample)
NZ (1) NZ740615A (enExample)
RU (2) RU2701513C2 (enExample)
SG (1) SG10201913222XA (enExample)
WO (1) WO2017085264A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2887977T3 (es) 2017-01-23 2021-12-29 Afyx Therapeutics As Método para la fabricación de un producto de dos capas a base de fibras electrohiladas
AU2018209592B2 (en) 2017-01-23 2024-03-21 Afyx Therapeutics A/S Method for preparing electrospun fibers with a high content of a bioadhesive substance
WO2021050532A1 (en) * 2019-09-09 2021-03-18 Afyx Therapeutics A/S Compositions for treating fungal infections
JP2022552832A (ja) 2019-10-08 2022-12-20 アフリックス セラピューティクス アー/エス タンパク質の送達のための組成物
EP4121017A4 (en) * 2020-03-17 2024-07-03 Blaesi, Aron H. EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR EXTENDED ACTIVE INGREDIENT RELEASE
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
EP4108231A1 (en) * 2021-06-25 2022-12-28 Johann-Wolfgang-Goethe-Universität Frankfurt am Main In-situ dissolving electrospun polymer fibers for ocular drug delivery
EP4124336B1 (en) * 2021-07-30 2023-10-25 Cannamedical Pharma GmbH Transmucosal patch comprising a cannabinoid and/or an opioid
JP2024542227A (ja) 2021-11-23 2024-11-13 アフリックス デベロップメント アー/エス 粘膜パッチおよびその使用方法
WO2024160792A1 (en) * 2023-01-30 2024-08-08 Cannamedical Pharma Gmbh Improved transmucosal patch comprising a cannabinoid and/or an opioid
WO2025051337A1 (en) 2023-09-06 2025-03-13 Afyx Development A/S Compositions and methods for treating and preventing oral cancer
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280423A (ja) 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor
JP2003521493A (ja) * 2000-01-28 2003-07-15 スミスクライン・ビーチャム・コーポレイション 電気紡糸された医薬組成物
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
AU2003265446A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
EP2271301A4 (en) * 2008-03-27 2014-07-02 Agigma Inc METHOD AND COMPOSITIONS FOR THE DELIVERY OF FUNDS
US20130295143A1 (en) * 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
CN102670483B (zh) * 2012-05-09 2014-04-02 上海交通大学 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法
WO2014066297A1 (en) * 2012-10-22 2014-05-01 North Carolina State University Nonwoven fiber materials
EP2810645B1 (en) * 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
CA2950821C (en) 2014-06-10 2024-02-06 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa

Also Published As

Publication number Publication date
AU2016358266A1 (en) 2018-04-05
EP3334412B1 (en) 2021-10-20
CA2993377A1 (en) 2017-05-26
HK1256209A1 (en) 2019-09-13
RU2701513C2 (ru) 2019-09-27
KR20190020173A (ko) 2019-02-27
DK3334412T3 (da) 2022-01-17
CA2993377C (en) 2019-11-12
AU2018220020A1 (en) 2018-09-06
JP2018528256A (ja) 2018-09-27
US20240139117A1 (en) 2024-05-02
KR102001163B1 (ko) 2019-07-18
KR102435996B1 (ko) 2022-08-25
WO2017085264A1 (en) 2017-05-26
RU2018109496A (ru) 2019-09-19
AU2016358266B2 (en) 2018-06-21
US20180221295A1 (en) 2018-08-09
ES2900741T3 (es) 2022-03-18
RU2019129082A (ru) 2020-04-28
EP3334412A1 (en) 2018-06-20
US20230285313A1 (en) 2023-09-14
JP6606279B2 (ja) 2019-11-13
KR20180040704A (ko) 2018-04-20
CN108135833A (zh) 2018-06-08
NZ740615A (en) 2019-06-28
US20190254985A1 (en) 2019-08-22
BR112018001978A2 (pt) 2018-09-18
MX2018005206A (es) 2018-08-01
SG10201913222XA (en) 2020-03-30
JP6929916B2 (ja) 2021-09-01
AU2018220020C1 (en) 2020-09-17
RU2018109496A3 (enExample) 2019-09-19
IL258093A (en) 2018-05-31
KR20190067280A (ko) 2019-06-14
IL258093B (en) 2022-03-01
CN108135833B (zh) 2022-11-29
MX391778B (es) 2025-03-21
JP2020022787A (ja) 2020-02-13
AU2018220020B2 (en) 2020-05-21

Similar Documents

Publication Publication Date Title
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
EP4302830A3 (en) Quinazoline derivatives used to treat hiv
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
CO6690766A2 (es) Composiciones agrícolas líquidas de estabilidad mejorada, y procesos para elaborar dichas composiciones
MX352907B (es) Composiciones de un poliortoéster y un solvente aprótico.
EA201492011A1 (ru) Безводные фармацевтические составы для местного применения
EA201890436A1 (ru) Жидкая полимерная система доставки для длительного введения лекарственных средств
MX380923B (es) Micropartículas cargadas con ciclosporina de liberación sostenida.
BR112016001544A8 (pt) composições farmacêuticas para a administração intraocular que compreende um agente antibacteriano e um agente anti-inflamatório
BR112017001093A2 (pt) formulação aquosa compreendendo paracetamol e ibuprofeno
MX382580B (es) Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos.
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
MX2016001607A (es) Microesferas de entecavir y composicion farmaceutica para administracion parenteral que contiene las mismas.
MX392770B (es) Composición farmacéutica de estabilidad mejorada.
BR112018007068A2 (pt) derivados de quinoxalina e piridopirazina como inibidores de pi3kbeta
PH12015502556A1 (en) Modified release formulation
NZ727834A (en) Fast acting orally disintegrating film
WO2016040814A3 (en) Disulfide polymers and methods of use
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
WO2016195194A3 (ko) 신규한 tlr2 길항제
MX2018009739A (es) La administración combinada de un agente de penetración y un compuesto que contiene azufre a plantas.
HK1223852A1 (zh) 睪丸酮凝膠組合物及相關方法
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
TR201903234T4 (tr) Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti.